Recently, the Shanxi Provincial Medical Insurance Bureau issued the "Notice on the Full Implementation of the Results of Selected Seventh Batch of Nationally Organized Drugs Centralized Procurement", and all public medical institutions in the province will fully implement the Res

Recently, the Shanxi Provincial Medical Insurance Bureau issued the "Notice on the Full Implementation of the Results of the Seventh Batch of National Organized Drugs Centralized Procurement", and all public medical institutions in the province will fully implement the Results of the Seventh Batch of National Organized Drugs Centralized Procurement from November 20.

There were 327 products selected in this procurement, with an average price reduction of 48%, involving 31 treatment categories, including hypertension , diabetes , anti-infection, digestive tract diseases and other common and chronic diseases, as well as medication for lung cancer, liver cancer , kidney cancer , and intestinal cancer.

Take the first-line targeted drug lunvatinib capsule of liver cancer as an example. Each pill has dropped from an average of 108 yuan to an average of 18 yuan, and one treatment cycle can save 8,100 yuan.

blood pressure lowering field, the delayed-controlled release dosage form was included for the first time, with the price of nifedipine controlled-release tablets being reduced by 58%, and the price of metoprolol sustained-release tablets being reduced by 53%, which significantly reduced the drug burden of patients with hypertension.

In addition, four varieties including tigecycline, micafungin, ebastin, iodapalol , have selected the original drugs, with an average price reduction of 67%.

After this centralized drug procurement is implemented, the number of national, provincial and inter-provincial alliance centralized drug procurement implemented by our province will reach 432, and 75 consumables (including 17 high-value and 58 low-value), with an average reduction of more than 50%, and a related cost saving of 5 billion yuan a year.

centralized volume-based procurement has effectively squeezed the inflated prices of related drug consumables, promoted the reduction of overall drug consumption prices, gradually reduced the burden of medical expenses for the masses, and made clinical diagnosis and treatment behaviors more standardized, the utilization rate of medical insurance fund continued to increase, and the medical purchase and sales environment has been effectively purified. The reform of linkage between medical, medical insurance and medicine has achieved obvious results, the people's sense of gain has been significantly improved, and the multi-sided positive effects have gradually emerged.

In the next step, our province will continue to play the important role of centralized volume-based procurement in improving people's livelihood, promoting the reform of three medical linkage, and promoting the healthy development of the pharmaceutical industry, continue to promote the acceleration and expansion of centralized volume-based procurement, promote the establishment and improvement of the price formation mechanism of pharmaceutical consumables, strive to guide the prices of pharmaceutical consumables to return to a reasonable level, effectively reduce the burden on medical expenses for the people, and let the effect of centralized procurement reform benefit the general public.